- LIG Nex1 unveils 2.75-Inch Low-Cost Guided Imaging Rocket during RIMPAC
LIG Nex1 introduced the 2.75-inch Low-Cost Guided Imaging Rocket during the Rim of the Pacific (RIMPAC) exercise, the world’s largest maritime exercise organized by the U.S.
RIMPAC, which marks its 28th anniversary this year, is a drill conducted by the U.S. Navy to enhance the ability to protect maritime routes and interoperate allies’ military capabilities among Pacific island countries. It is also a venue for networking among each country’s navies as well as for promotion for countries targeting the U.S., the world’s largest defense market.
LIG Nex1 said that it received great attention from navies of each country by displaying a low-cost guided imaging rocket that can be applied to vessels such as unmanned surface vehicles at the training site during RIMPAC.
A 2.75-inch low-cost guided imaging rocket was developed in 2016 to respond to target movements, and it is equipped with a guidance and control system in a small diameter of about 7cm and can respond to multiple targets at the same time.
In addition, it has great mobility by applying the mounting method, and the vehicle itself is equipped with both a target detection and a launch control device, allowing it to perform a solo mode operation.
As South Korea’s first guided weapon, the low-cost guided imaging rocket had excellent results in the U.S. FCT (Foreign Comparative Testing, a U.S. Defense Department Program to evaluate allies’ equipment and technologies) and proved performance.
LIG Nex1, a domestic guided weapon maker, has also conducted joint marketing with Raytheon, a leading U.S. defense company, to enter the U.S. defense market. In August 2021, it participated with Raytheon in the “Navy League’s Global Maritime Exposition” in Maryland, the US, to introduce the low-cost guided imaging rocket, and propose a launch pad system that can be applied to Unmanned Surface Vehicle for the navy on the ground.
- President Yoon visits Pangyo Information Protection Cluster
President Yoon Suk-yeol strongly expressed his government’s commitment to strengthen cyber security and raise the pride of workers in the field of personal information protection on the 13th.
President Yoon, who attended the 11th Information Protection Day ceremony held at Pangyo Information Protection Cluster, stressed that cybersecurity is key to national security and explained the government’s policy direction to strengthen cybersecurity in South Korea.
Regarding responding to the global rise in cyber security threats, President Yoon said, “We will strengthen the cybersecurity response system in which the private and public sectors closely cooperate and establish a comprehensive information sharing analysis system between the private and public so that we can efficiently prevent and respond to cyber security threats.”
He added, ” We will advance cyber military strength and technology to respond to a landscape in which wars tend to turn into hybrid warfare and strengthen cyber warfare capabilities by establishing ‘cyber Talpiot’, which links military service to employment and start-ups after discharge, and ‘cyber reserve forces for cyber warfare’ to unite public and private sectors’ capabilities in the state of national emergency.”
“We will expand the cyber security courses offered by universities and graduate schools (to solve the shortage of talented cybersecurity professionals), cultivate 100,000 experts through the development of elite developer personnel and white hacker growth system, and foster cyber security technology as a strategic industry,” he stressed.
Finally, he said, “We will quickly join the Convention on Cybercrime, also known as the Budapest Convention, and actively take part in international cooperation to fight cybercrime and establish cyber norms, which is the government’s will.”
At the ceremony, President Yoon awarded four people who have contributed to the development of information protection in South Korea the Nokjo Geun Jeong Medal, Industrial Service Medal, National Medal, and Presidential Commendation.
Professor Lee Ki-hyuk of Chung-Ang University, who contributed to the introduction of mobile identification from digital ID research for digital government services to the introduction of mobile driver’s licenses, won the Nokjo Geun-jeong Medal, the highest honor.
Ahn Soon-hong, CEO of Hanwha Techwin, received Industrial Service Medal for his contribution to the development of the video surveillance industry, Lim Gil-hwan, head of the Information Security Department of Korea Midland Power Co., Ltd., awarded National Medal for preparing a cyber defense system for important national facilities, and Kim Jin-man, team leader of Korea Internet & Security Agency, received Presidential Commendation for his contribution to improving the competitiveness of national information protection.
Pangyo Information Protection Cluster, where the event was held, is an iconic place to support the cooperation and growth of start-ups and human resources on information protection with infrastructure such as a real-life cyber training center, cyber education center, information protection start-up development space, and IoT test bed.
- SK Bioscience's “domestic no. 1 vaccine” effective against the omicron variant
SK Bioscience analyzed the cross-neutralization of booster shots through an extended study of phase 1/2 clinical trials of “SKYCovione GBP510,” a synthetic antigen-type COVID-19 vaccine, and confirmed the immune response to the omicron variant.
81 healthy adults got additional vaccination about seven months after getting two doses of basic vaccination of SKYCovione. It turns out the number of neutralizing antibodies that can induce preventive effects by neutralizing omicron infection increased by about 25 times compared to immediately after the primary series. In addition, it was about 72 times higher compared to seven months after the final dose in the primary series(right before a booster).
SKYCovione has previously proven its immunogenicity and safety through global clinical trials. In phase 3 global clinical trials of 4,037 adults aged 18 or older, it was confirmed that the antibody conversion rate, meaning the proportion of subjects whose neutralizing antibodies increased more than four times after vaccination, was 98% or higher. Neutralizing antibodies also increased about 33 times compared to before inoculation, and about three times more neutralizing antibodies were formed than those of the control vaccine.
In terms of safety, there was a similar level of adverse reaction rate compared to the control vaccine, and no special safety problems were reported during the clinical trial. SKYCovione’s global clinical trial and clinical analysis were supported by IVI (International Vaccine Institute), a not-for-profit international organization and the National Institute of Health’s Korea Vaccine Research Center, and domestic clinical trials were conducted at Korea University Guro Hospital.
In addition to the 1/2 phase extension study, SK Bioscience is verifying the possibility of SKYCovione’s various uses in the endemic era by conducting extension studies of existing three-phase clinical trials, conducting booster shot clinical trials of people vaccinated with other previously approved COVID-19 vaccines, in order to confirm the effectiveness against additional omicron variants. In particular, the market is expected to expand further as experts around the world are asking for additional COVID-19 vaccinations due to the re-emergence of the omicron variant.
Ahn Jae-yong, CEO of SK Bioscience, said, “As the world is slowly getting back to pre-pandemic normalcy after the prolong COVID-19 pandemic, new variants are constantly posing a threat to humanity,” adding, “We will do our best to prepare for the endemic era by accelerating the development of multivalent vaccines and universal vaccines using the platform as well as various clinical trials testing SKYCovione.”
Meanwhile, “SKYCovione,” which obtained approval from the Ministry of Food and Drug Safety in South Korea on the 29th of last month, is South Korea’s first COVID-19 vaccine developed through various global networks and cooperation led by SK Bioscience. It was jointly developed by SK Bioscience and the Institute for Protein Design (IPD) of the University of Washington, and supported by the Bill & Melinda Gates Foundation and the Coalition for Epidemic Preparedness Innovations (CEPI) throughout the entire development. Also, GlaxoSmithKline (GSK)’s immune-enhancer AS03 was applied to strengthen the immune response and induce a high level of neutralizing antibodies.
- Hankook Tire launches a brand ‘Laufenn’ strategically targeting the global market in South Korea
Hankook Tire & Technology has newly launched its global brand “Laufenn” in the domestic market.
Laufenn is Hankook Tire’s new brand that strategically target the global market to satisfy various tendencies and lifestyles of consumers around the world who aim for rational consumption.
Hankook Tire said, “Laufenn is characterized by its excellent quality, competitiveness and performance while having reasonable prices,” adding, “It has already proven its technological prowess and more than 7 million units are being sold annually in 80 countries, including Europe and the United States, which are advanced automobile markets.”
Hankook Tire will introduce a total of three all season tire products, including ‘S Fit AS’, ‘G Fit AS’, and ‘X Fit HT’ in South Korea. The product will be produced at Hankook Tire plants (Daejeon, Geumsan) and will continue to expand its competitiveness based on stable supply.
First of all, S Fit AS is an ultra-high-performance tire that provides excellent high-speed driving handling performance, soft and comfortable ride, and silence. Asymmetric patterns were applied, and efficient drainage was provided through four wide straight tread (tire in actual contact with the road surface) grooves, increasing braking power and driving performance even on wet surfaces.
G Fit AS is a daily comfort tire that provides optimal driving performance throughout four seasons even on a rain road in mid-summer and in winter. By applying a compound optimized for long mileage and evenly distributing the weight of the tire contact patch through optimized profile (contour) technology, irregular wear is minimized and gas mileage is improved.
Finally, ‘X Fit HT’ is an on-road SUV tire that combines ride comfort with durability. Through 3D vibration analysis technology, silent driving is possible when driving, and adjustment stability and durability are enhanced even during high-speed cornering with tie-bar technology that connects blocks. In addition, it has secured high driving stability by implementing excellent traction and braking power through tire tread with zig-zag grooves.
Meanwhile, Laufenn has carried out sports marketing by officially sponsoring the UEFA Europa League, the top European professional league football tournament and Major League Baseball, a US professional baseball organization. It is also strengthening communication with consumers around the world through more than 20 Laufenn websites built in major languages such as South Korea, Europe, and the United States.
An official from Hankook Tire said, “We will step up efforts to target the market with a multi-brand strategy to satisfy consumers’ diverse tastes. We plan to differentiate our competitiveness by simultaneously operating Hankook Tire, a premium brand that aims to achieve the highest level of performance, and Laufenn, a strategic brand that optimizes its product lineup to be faithful to the basic function of tires, targeting smart and reasonable consumers.”
Short news
- Kakao Brain-Galux conduct research on a new drug design platform based on AI
AI-based antibody new drug design technology is a field where global companies are competing fiercely. It is called a dream new technology that will change the paradigm of new drug development in that it can be applied to curing various incurable diseases.
Under the contract, the two companies will develop an AI-based antibody new drug design platform to create new antibody treatments. They will push ahead with an antigen-antibody binding structure and binding force prediction as a base technology, antibody design applying underlying technology and experimental validation of design technology for the next five years based on Kakao Brain's know-how in developing ultra-large AI technology and Galux's protein design technology.
- Naver Cloud launches a workbox e-contract service
Workbox, a cloud-based file sharing service, supports a secure and efficient collaboration environment through strong security. File sharing is possible anywhere with any device, and files can be safely managed with real-time synchronization and recovery functions. Using the newly linked electronic contract service, you can process from electronic signature to contract management all at once in the workbox. It is possible to create electronic contract documents and request electronic signatures immediately in the workbox, which can increase work efficiency.
Naver Cloud signed an MOU with Glosign, an e-contract service, last month.
- Kakao Mobility opens a reservation service for Kakao T Taxi app and airport pickup service in Guam
Kakao T overseas reservation is a service that allows users to book and use various means of transportation, including local taxis, through the Kakao T app. Kakao Mobility has collaborated with Miki Taxi Service, Guam's largest taxi brand, to implement the service.
Taxi and airport pickup reservation services are available through overseas travel menus on the Travel tab within the Kakao T app, and user can also access through a recommended link service when booking tickets for Guam through Kakao T international flight.
Considering user convenience, Kakao Mobility also has a locally customized system such as automatic translation of messages between drivers and passengers, "safe message function" where users can share expected arrival time, insurance purchase for all vehicles, and 24-hour operation of local customer centers for Koreans.
Source: Pangyo Techno Valley Official Newsroom